Reply to Rodriguez-Peralvarez et al

The cumulative incidence of COVID-19 among liver transplant (LT) recipients was highly variable in different European countries in the early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR). In contrast to the national studies, the strength of ELITA-ELTR study is a better description of the incidence of COVID-19 in LT recipients at the European level at the beginning of the pandemic. Broader definition of symptomatic COVID-19 could be the reason for overestimation of the incidence of COVID-19 in some centers compared to the Spanish nationwide study. Combining data from all European countries in one platform/study would provide a unique opportunity to monitor the incidence of COVID-19 in liver transplantation setting, adding a dynamic dimension to our first report, and most importantly to collect additional information on treatment strategies to optimize the management of COVID 19 in the very special population of LT recipients.